More Press Releases

View Older Stories View Newer Stories

Nov 4, 2026 04:04PM Arm Holdings plc Reports Results for the Second Quarter of the Fiscal Year Ending 2027
Nov 4, 2026 04:03PM Onterris Reports Third Quarter Results, Reiterates Full-Year 2026 Guidance, Announces Completed Acquisitions, and Provides Update on Board-led Strategic Review Process
Nov 4, 2026 04:03PM Vertex Announces Third Quarter 2026 Financial Results
Nov 4, 2026 04:02PM Metals Creek Resources Corp. Files for Approval of $800,000 Flow-Through Private Placement
Nov 4, 2026 04:02PM Eyemart Express Offers Veterans and Military Families 20% Off Glasses This Veterans Day
Nov 4, 2026 04:02PM Green Thumb Industries Reports Third Quarter 2026 Results
Nov 4, 2026 04:02PM Niagen Bioscience, Inc. Reports Third Quarter 2026 Financial Results
Nov 4, 2026 04:02PM GRAIL Reports Third Quarter 2026 Financial Results
Nov 4, 2026 04:02PM Revolution Medicines Reports Third Quarter 2026 Financial Results and Update on Corporate Progress
Nov 4, 2026 04:02PM Aeva Expands Product Portfolio for Optical Connectivity Market
Nov 4, 2026 04:02PM AI and Frontline Teams Adoption Drive Strong Q2 CX Growth at 8x8
Nov 4, 2026 04:02PM Permian Resources Declares Quarterly Cash Dividend
Nov 4, 2026 04:02PM Veeco Reports Third Quarter 2026 Financial Results
Nov 4, 2026 04:02PM Baird Medical Issues Statement Regarding Recent Share Price Volatility
Nov 4, 2026 04:02PM HMH Holding Inc. Announces Third Quarter 2026 Results
Nov 4, 2026 04:01PM Stellantis Appoints Pablo Di Si Chief Operating Officer, North America and American Brands
Nov 4, 2026 04:01PM Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 2026 Financial Results
Nov 4, 2026 04:01PM Magnolia Oil & Gas Corporation Announces Third Quarter 2026 Results
Nov 4, 2026 04:01PM LegalZoom Reports Third Quarter 2026 Financial Results
Nov 4, 2026 04:01PM STAAR Surgical Reports Third Quarter 2026 Results
Nov 4, 2026 04:01PM Cirrus Logic Reports Fiscal Second Quarter Revenue of $559.5 Million
Nov 4, 2026 04:01PM Expedia Group Reports Third Quarter 2026 Results
Nov 4, 2026 04:01PM Lumine Group Inc. Announces Results for the Third Quarter Ended September 30, 2026
Nov 4, 2026 04:01PM Magnachip Reports Results for Third Quarter 2026
Nov 4, 2026 04:01PM Celldex to Present at Upcoming Investor Conferences
Nov 4, 2026 04:01PM Xencor Reports Third Quarter 2026 Financial Results
Nov 4, 2026 04:01PM Power Integrations Reports Third-Quarter Financial Results
Nov 4, 2026 04:01PM Maravai LifeSciences Reports Third Quarter 2026 Financial Results
Nov 4, 2026 04:01PM Lumen Technologies Reports Solid Third Quarter 2026 Results; Strategic Growth and Operating Leverage Gain Momentum
Nov 4, 2026 04:01PM PTC ANNOUNCES FOURTH FISCAL QUARTER AND FULL FISCAL YEAR 2026 RESULTS
Nov 4, 2026 04:01PM Clipper Realty Inc. Announces Third Quarter 2026 Results
Nov 4, 2026 04:01PM Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 4, 2026 04:01PM Asure Software Sets November and December 2026 Investor Conference Schedule
Nov 4, 2026 04:01PM BioCryst to Present at Upcoming Investor Conferences
Nov 4, 2026 04:01PM IM Cannabis Raises US$1,200,000 of Gross Proceeds in Convertible Note Financing
Nov 4, 2026 04:01PM Edgewise Therapeutics Reports Third Quarter 2026 Financial Results
Nov 4, 2026 04:01PM Personalis Reports Third Quarter Results
Nov 4, 2026 04:01PM Gulfport Energy Reports Third Quarter 2026 Financial and Operating Results
Nov 4, 2026 04:01PM PureCycle Technologies Reports Third Quarter 2026 Results
Nov 4, 2026 04:01PM MercadoLibre, Inc. Reports Third Quarter 2026 Financial Results
Nov 4, 2026 04:01PM Oxford Lane Capital Corp. Announces Full Redemption of 5.00% Notes Due 2027
Nov 4, 2026 04:01PM Progyny, Inc. Announces Third Quarter 2026 Results
Nov 4, 2026 04:01PM Sunrun Reports Third Quarter 2026 Financial Results
Nov 4, 2026 04:01PM Baird Medical Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Nov 4, 2026 04:01PM Olema Oncology to Present Combination Data from the Palazestrant and OP-3136 Programs at the 2026 San Antonio Breast Cancer Symposium
Nov 4, 2026 04:01PM Arvinas to Present Preliminary Clinical Data from Early Monotherapy Dose Escalation Cohorts in the Phase 1 Trial for ARV-393 (Zaloblideg), a PROTAC BCL6 Degrader, at the 2026 American Society of Hemat
Nov 4, 2026 04:01PM Sezzle Reports Third Quarter 2026 Results
Nov 4, 2026 04:01PM Global Water Resources Receives ACC Approval for Rate Increase for GW-Santa Cruz
Nov 4, 2026 04:01PM Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 4, 2026 04:01PM Design Therapeutics Announces Third Quarter 2026 Financial Results and Recent Business Updates
View Newer Stories View Older Stories